CORRECTING and REPLACING Expensify Announces Q2 2022 Results
The company experienced its strongest quarter for paid member growth to date, generated year-over-year interchange growth from the Expensify Card of
The updated release reads:
EXPENSIFY ANNOUNCES Q2 2022 RESULTS
The company experienced its strongest quarter for paid member growth to date, generated year-over-year interchange growth from the Expensify Card of
“Our paid member count has fully rebounded and currently exceeds pre-pandemic levels, so there’s a lot to be excited about,” said
“We delivered great results this quarter anchored by an increase in subscription revenue and Expensify Card interchange,” says
Second Quarter 2022 Highlights
Financial:
-
Revenue was
, an increase of$43.2 million 22% compared to the same period last year. -
Interchange derived from the Expensify Card saw sequential quarterly growth of
40% , resulting in a142% increase compared to the same period last year. -
Positive operating cash flows of
.$15.9 million -
Net (loss) income was
, compared to$(8.0) million for the same period last year. This loss was primarily driven by stock-based compensation expenses of$6.6 million .$14.0 million -
Non-GAAP net income was
.$6.1 million
-
Non-GAAP net income was
-
Adjusted EBITDA was
, with an Adjusted EBITDA margin of$11.7 million 27% .
Business
- Paid members - a strong Q2 propelled quarterly paid members for the quarter to 754,000 compared to 706,000 in Q1.
-
ExpensiCon - the third-ever, invite-only accounting retreat is returning
May 2023 , this time bringing industry thought-leaders to the legendary Borgo Egnazia in Puglia,Italy . -
Awards
- Expensify’s employee-controlled compensation program earned two finalist spots as part of Fast Company’s World Changing Ideas Awards.
-
Expensify also won multiple workplace awards for 2022, with Fortune designating the company one of the best small workplaces and theSan Francisco Chronicle ranking it one of the top workplaces in theBay Area .
Financial Outlook
We reaffirm our long term guidance provided in connection with our fourth quarter 2021 results of 25
Est. stock-based compensation (millions) |
|||||||||||||||||
|
|
|
|||||||||||||||
|
Q3 2022 |
|
Q4 2022 |
|
Q1 2023 |
||||||||||||
|
Low |
|
High |
|
Low |
|
High |
|
Low |
|
High |
||||||
Cost of revenue, net |
$ |
4.4 |
|
$ |
5.1 |
|
$ |
3.6 |
|
$ |
4.3 |
|
$ |
3.4 |
|
$ |
4.1 |
Research and development |
|
1.8 |
|
|
2.0 |
|
|
1.4 |
|
|
1.7 |
|
|
1.4 |
|
|
1.6 |
General and administrative |
|
5.1 |
|
|
5.9 |
|
|
4.2 |
|
|
4.9 |
|
|
4.0 |
|
|
4.7 |
Sales and marketing |
|
1.9 |
|
|
2.2 |
|
|
1.5 |
|
|
1.8 |
|
|
1.5 |
|
|
1.7 |
Total |
$ |
13.2 |
|
$ |
15.2 |
|
$ |
10.7 |
|
$ |
12.7 |
|
$ |
10.3 |
|
$ |
12.1 |
|
|
|
|
|
|
|
|
|
|
|
|
Availability of Information on Expensify’s Website
Investors and others should note that
Conference Call
Non-GAAP Financial Measures
In addition to financial measures prepared in accordance with
We believe our non-GAAP financial measures are useful in evaluating our business, measuring our performance, identifying trends affecting our business, formulating business plans and making strategic decisions. Accordingly, we believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our results of operations in the same manner as our management team. These non-GAAP financial measures are presented for supplemental informational purposes only, should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from similarly titled metrics or measures presented by other companies. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently or may use other measures to evaluate their performance. All of these limitations could reduce the usefulness of these non-GAAP financial measures as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate our business. A reconciliation of each non-GAAP financial measure to the most directly comparable financial measure stated in accordance with GAAP is at the end of this press release.
Adjusted EBITDA. We define adjusted EBITDA as net income from operations excluding provision for income taxes, interest and other expenses, net, depreciation and amortization and stock based compensation.
Adjusted EBITDA margin. We define adjusted EBITDA margin as adjusted EBITDA divided by total revenue for the same period.
Non-GAAP net income. We define non-GAAP net income as net income from operations in accordance with US GAAP excluding stock-based compensation and IPO-related bonus costs. Prior to the four quarter of 2021, this metric only excluded IPO-related bonus costs and did not exclude expenses related to stock-based compensation. However, management now believes that further excluding stock-based compensation from non-GAAP net income is useful to better understand the financial performance of our business and to facilitate a better comparison of our results to those of peer companies over multiple periods given that this item may vary between companies for reasons unrelated to overall operating performance. IPO-related bonus costs impacted the second, third and fourth fiscal quarters of 2021 but did not impact the first or second quarters of 2022 and are not expected to impact future periods.
Non-GAAP net income margin. We define non-GAAP net income as non-GAAP net income divided by total revenue for the same period.
The tables at the end of the Condensed Consolidated Financial Statements provide reconciliations to the most directly comparable GAAP financial measure to each of these non-GAAP financial measures.
Forward-Looking Statements
Forward-looking statements in this press release, or made during the earnings call, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1955. These statements include statements regarding our strategy, future financial condition, future operations, projected costs, prospects, plans, objectives of management and expected market growth and involve known and unknown risks that are difficult to predict. As a result, our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “shall,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “goal,” “objective,” “seeks,” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: the economic, political and social impact of, and uncertainty relating to, the COVID-19 pandemic; the war in
About
Condensed Consolidated Balance Sheets (unaudited, in thousands, except share and per share data) |
|||||||
|
As of |
|
As of |
||||
|
|
2022 |
|
|
|
2021 |
|
Assets |
|
|
|
||||
Cash and cash equivalents |
$ |
105,537 |
|
|
$ |
98,398 |
|
Accounts receivable, net |
|
16,270 |
|
|
|
15,713 |
|
Settlement assets |
|
43,780 |
|
|
|
21,880 |
|
Prepaid expenses |
|
5,430 |
|
|
|
7,436 |
|
Related party loan receivable |
|
— |
|
|
|
14 |
|
Other current assets |
|
20,434 |
|
|
|
14,201 |
|
Total current assets |
|
191,451 |
|
|
|
157,642 |
|
Capitalized software, net |
|
6,006 |
|
|
|
6,359 |
|
Property and equipment, net |
|
15,174 |
|
|
|
15,930 |
|
Lease right-of-use assets |
|
1,472 |
|
|
|
2,202 |
|
Deferred tax assets, net |
|
689 |
|
|
|
370 |
|
Other assets |
|
580 |
|
|
|
710 |
|
Total assets |
$ |
215,372 |
|
|
$ |
183,213 |
|
Liabilities and stockholders' equity |
|
|
|
||||
Accounts payable |
$ |
2,169 |
|
|
$ |
3,752 |
|
Accrued expenses and other liabilities |
|
8,967 |
|
|
|
11,046 |
|
Borrowings under line of credit |
|
15,000 |
|
|
|
15,000 |
|
Current portion of long-term debt, net of original issuance discount and debt issuance costs |
|
548 |
|
|
|
549 |
|
Lease liabilities, current |
|
1,508 |
|
|
|
1,549 |
|
Settlement liabilities |
|
41,590 |
|
|
|
21,680 |
|
Total current liabilities |
|
69,782 |
|
|
|
53,576 |
|
Lease liabilities, non-current |
|
68 |
|
|
|
802 |
|
Other liabilities |
|
1,121 |
|
|
|
153 |
|
Long-term debt, net of original issuance discount and debt issuance costs |
|
51,710 |
|
|
|
52,067 |
|
Total liabilities |
|
122,681 |
|
|
|
106,598 |
|
Commitments and contingencies (Note 4) |
|
|
|
||||
Stockholders' equity: |
|
|
|
||||
Common stock, par value |
|
6 |
|
|
|
6 |
|
Additional paid-in capital |
|
173,961 |
|
|
|
142,515 |
|
Accumulated deficit |
|
(81,276 |
) |
|
|
(65,906 |
) |
Total stockholders' equity |
|
92,691 |
|
|
|
76,615 |
|
Total liabilities and stockholders' equity |
$ |
215,372 |
|
|
$ |
183,213 |
|
|
|
|
|
||||
Condensed Consolidated Statements of Operations (unaudited, in thousands, except share and per share data) |
|||||||||||||||
|
Three months ended |
|
Six months ended |
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
|
(in thousands, except per share data) |
||||||||||||||
Revenue |
$ |
43,162 |
|
|
$ |
35,304 |
|
|
$ |
83,532 |
|
|
$ |
65,024 |
|
Cost of revenue, net(1) |
|
15,876 |
|
|
|
7,934 |
|
|
|
30,010 |
|
|
|
15,571 |
|
Gross margin |
|
27,286 |
|
|
|
27,370 |
|
|
|
53,522 |
|
|
|
49,453 |
|
Operating expenses: |
|
|
|
|
|
|
|
||||||||
Research and development(1) |
|
3,584 |
|
|
4,874 |
|
|
|
7,285 |
|
|
|
5,971 |
|
|
General and administrative(1) |
|
15,432 |
|
|
|
11,127 |
|
|
|
29,438 |
|
|
|
17,494 |
|
Sales and marketing(1) |
|
12,244 |
|
|
|
3,870 |
|
|
|
25,616 |
|
|
|
6,947 |
|
Total operating expenses |
|
31,260 |
|
|
|
19,871 |
|
|
|
62,339 |
|
|
|
30,412 |
|
(Loss) income from operations |
|
(3,974 |
) |
|
|
7,499 |
|
|
|
(8,817 |
) |
|
|
19,041 |
|
Interest and other expenses, net |
|
(1,955 |
) |
|
|
(769 |
) |
|
|
(2,856 |
) |
|
|
(1,506 |
) |
(Loss) income before income taxes |
|
(5,929 |
) |
|
|
6,730 |
|
|
|
(11,673 |
) |
|
|
17,535 |
|
Provision for income taxes |
|
(2,065 |
) |
|
|
(99 |
) |
|
|
(3,697 |
) |
|
|
(2,861 |
) |
Net (loss) income |
$ |
(7,994 |
) |
|
$ |
6,631 |
|
|
$ |
(15,370 |
) |
|
$ |
14,674 |
|
|
|
|
|
|
|
|
|
||||||||
Less: income allocated to participating securities |
|
— |
|
|
|
(4,706 |
) |
|
|
— |
|
|
|
(9,426 |
) |
Net (loss) income attributable to Class A, LT10 and LT50 common stockholders |
$ |
(7,994 |
) |
|
$ |
1,925 |
|
|
$ |
(15,370 |
) |
|
$ |
5,248 |
|
Net (loss) income per share attributable to Class A, LT10 and LT50 common stockholders: |
|
|
|
|
|
|
|
||||||||
Basic |
$ |
(0.10 |
) |
|
$ |
0.06 |
|
|
$ |
(0.19 |
) |
|
$ |
0.18 |
|
Diluted |
$ |
(0.10 |
) |
|
$ |
0.05 |
|
|
$ |
(0.19 |
) |
|
$ |
0.13 |
|
Weighted-average shares of common stock used to compute net (loss) income per share attributable to Class A, LT10 and LT50 common stockholders: |
|
|
|
|
|
|
|
||||||||
Basic |
|
80,473,097 |
|
|
|
29,836,295 |
|
|
|
80,311,053 |
|
|
|
29,680,220 |
|
Diluted |
|
80,473,097 |
|
|
|
41,341,330 |
|
|
|
80,311,053 |
|
|
|
41,216,420 |
|
|
|
|
|
|
|
|
|
(1) Includes stock-based compensation expense as follows: |
|||||||||||
|
Three months ended |
|
Six months ended |
||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
Cost of revenue, net |
$ |
4,704 |
|
$ |
237 |
|
$ |
9,611 |
|
$ |
425 |
Research and development |
|
1,877 |
|
|
174 |
|
|
4,298 |
|
|
328 |
General and administrative |
|
5,463 |
|
|
404 |
|
|
10,439 |
|
|
708 |
Sales and marketing |
|
2,004 |
|
|
73 |
|
|
4,080 |
|
|
137 |
Total stock-based compensation expense |
$ |
14,048 |
|
$ |
888 |
|
$ |
28,428 |
|
$ |
1,598 |
|
|
|
|
|
|
|
|
||||
Condensed Consolidated Statements of Cash Flows (unaudited, in thousands) |
|||||||
|
Six months ended |
||||||
|
|
2022 |
|
|
|
2021 |
|
Cash flows from operating activities: |
|
|
|
||||
Net (loss) income |
$ |
(15,370 |
) |
|
$ |
14,674 |
|
Adjustments to reconcile net (loss) income to net cash provided by operating activities: |
|
|
|
||||
Depreciation and amortization |
|
2,735 |
|
|
|
2,294 |
|
Reduction of operating lease right-of-use assets |
|
358 |
|
|
|
365 |
|
Loss on impairment, receivables and sale or disposal of equipment |
|
475 |
|
|
|
133 |
|
Stock-based compensation |
|
28,428 |
|
|
|
1,598 |
|
Amortization of original issuance discount and debt issuance costs |
|
21 |
|
|
|
16 |
|
Deferred tax assets |
|
(319 |
) |
|
|
— |
|
Changes in assets and liabilities: |
|
|
|
||||
Accounts receivable, net |
|
(906 |
) |
|
|
(3,513 |
) |
Settlement assets |
|
(8,999 |
) |
|
|
(2,996 |
) |
Prepaid expenses |
|
2,006 |
|
|
|
(1,542 |
) |
Related party loan receivable |
|
14 |
|
|
|
(291 |
) |
Other current assets |
|
1,193 |
|
|
|
855 |
|
Other assets |
|
2 |
|
|
|
20 |
|
Accounts payable |
|
(1,583 |
) |
|
|
(1,335 |
) |
Accrued expenses and other liabilities |
|
(1,366 |
) |
|
|
6,768 |
|
Operating lease liabilities |
|
(404 |
) |
|
|
(406 |
) |
Settlement liabilities |
|
19,910 |
|
|
|
7,101 |
|
Other liabilities |
|
963 |
|
|
|
472 |
|
Net cash provided by operating activities |
|
27,158 |
|
|
|
24,213 |
|
Cash flows from investing activities: |
|
|
|
||||
Purchases of property and equipment |
|
(267 |
) |
|
|
(1,940 |
) |
Software development costs |
|
(468 |
) |
|
|
(1,353 |
) |
Net cash used by investing activities |
|
(735 |
) |
|
|
(3,293 |
) |
Cash flows from financing activities: |
|
|
|
||||
Principal payments of finance leases |
|
(394 |
) |
|
|
(385 |
) |
Principal payments of term loan |
|
(297 |
) |
|
|
(1,231 |
) |
Repurchases of early exercised stock options |
|
(20 |
) |
|
|
— |
|
Proceeds from common stock purchased under Matching Plan |
|
1,188 |
|
|
|
— |
|
Payments of deferred offering costs |
|
— |
|
|
|
(3,343 |
) |
Proceeds from issuance of common stock on exercise of stock options |
|
519 |
|
|
|
971 |
|
Net cash provided (used) by financing activities |
|
996 |
|
|
|
(3,988 |
) |
Net increase in cash and cash equivalents and restricted cash |
|
27,419 |
|
|
|
16,932 |
|
Cash and cash equivalents and restricted cash, beginning of period |
|
125,315 |
|
|
|
46,878 |
|
Cash and cash equivalents and restricted cash, end of period |
$ |
152,734 |
|
|
$ |
63,810 |
|
Supplemental disclosure of cash flow information: |
|
|
|
||||
Cash paid for interest |
$ |
1,750 |
|
|
$ |
1,445 |
|
Cash paid for income taxes |
$ |
606 |
|
|
$ |
5,122 |
|
Noncash investing and financing items: |
|
|
|
||||
Accrued deferred offering costs |
$ |
— |
|
|
$ |
821 |
|
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets |
|
|
|
||||
Cash and cash equivalents |
$ |
105,537 |
|
|
$ |
45,429 |
|
Restricted cash included in other current assets |
|
16,077 |
|
|
|
3,652 |
|
Restricted cash included in other assets |
|
— |
|
|
|
49 |
|
Restricted cash included in settlement assets |
|
31,120 |
|
|
|
14,680 |
|
Total cash, cash equivalents and restricted cash |
$ |
152,734 |
|
|
$ |
63,810 |
|
|
|
|
|
||||
Reconciliation of GAAP to Non-GAAP Financial Measures (unaudited, in thousands, except percentages) |
|||
Adjusted EBITDA and Adjusted EBITDA Margin |
|||
|
Three months ended |
||
|
2022 |
||
Net (loss) income |
$ |
(7,994 |
) |
Net (loss) income margin |
|
(19 |
)% |
Add: |
|
||
Provision for income taxes |
|
2,065 |
|
Interest and other expenses, net |
|
1,955 |
|
Depreciation and amortization |
|
1,582 |
|
Stock-based compensation |
|
14,048 |
|
Adjusted EBITDA |
$ |
11,656 |
|
Adjusted EBITDA margin |
|
27 |
% |
|
|
Non-GAAP Net Income and Non-GAAP Net Income Margin |
|||
|
Three months ended |
||
|
2022 |
||
Net (loss) income |
$ |
(7,994 |
) |
Net (loss) income margin |
|
(19 |
)% |
Add: |
|
||
Stock-based compensation |
|
14,048 |
|
IPO-related bonus expense |
|
— |
|
Non-GAAP net income |
$ |
6,054 |
|
Non-GAAP net income margin |
|
14 |
% |
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220811005576/en/
Investor Relations Contact
investors@expensify.com
Press Contact
press@expensify.com
Source: